Review
Published on 07 Jul 2021
Effect of the Hypoxia Inducible Factor on Sorafenib Resistance of Hepatocellular Carcinoma
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2021.641522
- 6,452 views
- 26 citations
Type at least 3 characters
1,009 articles
Articles
Systematic Review
Published on 07 Jul 2021
Cancer Preventive and Therapeutic Potential of Banana and Its Bioactive Constituents: A Systematic, Comprehensive, and Mechanistic Review
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2021.697143
- 42,490 views
- 44 citations
Original Research
Published on 06 Jul 2021
Cucurbitacin B Inhibits Cell Proliferation by Regulating X-Inactive Specific Transcript Expression in Tongue Cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2021.651648
- 3,995 views
- 20 citations
Systematic Review
Published on 06 Jul 2021
Zusanli (ST36) Acupoint Injection With Dexamethasone for Chemotherapy-Induced Myelosuppression: A Systematic Review and Meta-Analysis
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2021.684129
- 3,248 views
- 3 citations
Case Report
Published on 05 Jul 2021
Case Report: Severe Rashes Associated With Fruquintinib in a Patient With Metastatic Colorectal Cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2021.688231
- 2,593 views
- 2 citations
Brief Research Report
Published on 02 Jul 2021
Exploring the Significance of the Exon 4-Skipping Isoform of the ZNF217 Oncogene in Breast Cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2021.647269
- 3,040 views
- 4 citations
Original Research
Published on 02 Jul 2021
Feiyanning Formula Induces Apoptosis of Lung Adenocarcinoma Cells by Activating the Mitochondrial Pathway
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2021.690878
- 4,110 views
- 10 citations
Retraction
Published on 29 Jun 2021
Retraction: Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Squamous Cell Carcinoma by Down-Regulating NF-kB/COX-2/VEGF Pathway
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2021.721658
- 3,293 views
- 1 citation
Case Report
Published on 28 Jun 2021
Case Report: Low-Dose Apatinib in the Treatment of Intrahepatic Biliary Cystadenoma With Recurrence and Malignant Transformation
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2021.676092
- 2,283 views
- 2 citations
Case Report
Published on 28 Jun 2021
Efficacy of Anlotinib for the Treatment of Angiosarcoma of the Face and Neck: A Case Report
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2021.596732
- 3,256 views
- 6 citations
Systematic Review
Published on 25 Jun 2021
Efficacy and Safety of Camrelizumab Monotherapy and Combination Therapy for Cancers: A Systematic Review and Meta-Analysis
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2021.695512
- 5,497 views
- 13 citations
Original Research
Published on 25 Jun 2021
The Antitumor Activity and Mechanism of a Natural Diterpenoid From Casearia graveolens
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2021.688195
- 2,271 views
- 14 citations
Original Research
Published on 24 Jun 2021
Enhanced Drug Delivery to Solid Tumors via Drug-Loaded Nanocarriers: An Image-Based Computational Framework
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2021.655781
- 6,093 views
- 51 citations
Original Research
Published on 24 Jun 2021
A Novel Ruthenium(II) Complex With Lapachol Induces G2/M Phase Arrest Through Aurora-B Kinase Down-Regulation and ROS-Mediated Apoptosis in Human Prostate Adenocarcinoma Cells
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2021.682968
- 3,631 views
- 18 citations
Case Report
Published on 24 Jun 2021
Case Report: Long-Term Survival With Anlotinib in a Patient With Advanced Undifferentiated Large-Cell Lung Cancer and Rare Tonsillar Metastasis
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2021.680818
- 3,032 views
- 3 citations
Case Report
Published on 23 Jun 2021
Case Report: Paclitaxel-Induced Pneumonitis in Early Breast Cancer: A Single Institution Experience and Review
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2021.701424
- 9,790 views
- 8 citations